Navigation Links
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug

Samaritan Announces Positive Data in Nonclinical (IND) In- Vitro Studies for Promising Alzheimer's Drug

LAS VEGAS, May 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce positive results were attained with its late-stage preclinical/nonclinical testing of Caprospinol (SP-233), with well recognized in-vitro models.

Although nonclinical research results are imperfect predictors of clinical responses, laboratory animals remain the best experimental models for identifying and measuring a compound's biological activity and for predicting a drug's clinical effects. Because animal studies are performed before and during clinical studies, the term "nonclinical" is generally preferred to preclinical when discussing the full spectrum of in-vitro and non-human in-vivo tests associated with drug development. By studying a drug's dose-response characteristics, adverse and residual effects, Samaritan and the FDA gain valuable insights, as to a drug's probable action, and effect in humans.

Samaritan completed a series of in-vitro studies to determine SP-233's metabolic stability in liver microsomes. SP-233's results were positive since it was reported to be stable in all four species tested: human, dog, rat and mouse species. The metabolic stability of a drug candidate, e.g., drug substance in liver microsomes of different species, is determined in order to assess the potential of SP-233 to form undesired potentially toxicity or pharmacologically inactive metabolites.

In addition, positive results were reported where SP-233 was shown to have no CYP inhibition potential for CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 suggesting that SP-233, is unlikely to cause, or alter the metabolism of co-administered drugs, and thus cause, a drug-drug interaction, which could give rise to severe side effects.

Dr. Janet Greeson, CEO of Sam
'"/>




Page: 1 2 3

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/29/2014)... 29, 2014 /PRNewswire-iReach/ -- MHG Medical Management Services, ... its Medical Equipment and X-ray Annual Inspection ... tailored to the cruise industry,s unique requirements.  MHG ... to propose that they should develop a new ... is intended to create standardized processes and raise ...
(Date:7/29/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... 2014 Clinical Lab Expo today by unveiling two booths ... is partnering with customers to redefine the value of ... day that they,re looking for a partner to help ... and offices," said Jack Phillips , president and ...
(Date:7/29/2014)... 2014  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... second quarter 2014 financial results after the Nasdaq market ... host a live conference call and webcast to discuss ... morning, August 7, 2014 at 8:00 a.m. Eastern Time ... the live conference call by dialing 866-952-1907 (US) or ...
Breaking Medicine Technology:MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... St. Petersburg, FL (PRWEB) July 30, 2014 Phytceramides ... explains how and why in her new book. , Today is ... Phytoceramides: Anti Aging At Its Best . The book is ... larger skin care book, but felt that Phytoceramides were ... sense to bring out this focused book now," says Kathy Heshelow, ...
(Date:7/29/2014)... Daily Gossip indicates that the new method ... symptoms that hemorrhoids commonly causes. The new method was ... expert. , The author of H Miracle reveals ... symptoms such as itching, burning, pain and swelling, as ... H Miracle by visiting the official website at: ...
(Date:7/29/2014)... 29, 2014 Daily Gossip reveals in its ... program claims that he cured his condition with the use ... share part of his experience. , He claimed that ... naturally in just 4 days. Since his method turned out ... from all around the world. , The Nasal Polyps ...
(Date:7/29/2014)... 29, 2014 DailyGossip.org reveals in its ... is a new method of naturally overcoming sciatica, in ... the new method ensure sufferers that the cure is ... , The new method is described as very ... sciatica with an 8 minutes per day treatment plan. ...
(Date:7/29/2014)... DailyGossip.org reveals in its latest review that ... can perfectly understand patients and what they have to go ... is the author of the new program. Ellie claims that ... suffering, Ellie started her very own research. Four years passed ... author of the Get Rid of Cold Sores program claims ...
Breaking Medicine News(10 mins):Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2Health News:Nasal Polyps Treatment Miracle Review Reveals How to Cure Nasal Polyps Without Surgery 2Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Get Rid of Cold Sores Fast Review Exposes the Way to Stop Outbreaks 2
... apnea, a dangerous medical condition that becomes more prevalent as ... deadly if left// untreated, says an expert. ,The ... irritation, with people being unaware that they are causing more ... the online edition of health portal News Medical. ...
... 'An ounce of prevention is worth a pound of cure.' , ... disease that could wipe the smile// off many faces and cause ... 43% of all cancers are preventable. Sunday, 4 February 2007, is ... will focus on strategies for a cancer free world – a ...
... College of Medicine finds that naltrexone may be beneficial to ... is often used to bring// relief to victims of alcohol ... inflammatory disorder of the intestine that affects an estimated 500,000 ... an early edition of the American Journal of Gastroenterology. ...
... hair dye are increasing as more and younger people dye ... dermatitis on the face and, in severe cases, facial swelling ... dyes currently contain para-phenylenediamine (PPD) and other related agents. During ... serious problem that it was banned from hair dyes in ...
... A promising step forward in the field of AIDS was ... to this 2-5AN6B, a nucleic acid, could actually stop the// ... ,This work was led by Robert J.Suhadolnik, Professor of ... 2-5AN6B in combination with drugs currently used for AIDS treatment ...
... menstrual cycles affect the responsiveness of their brains’ reward ... Mental Health (NIMH), a component of the National Institutes ... women were winning rewards, their circuitry was more active ... and dominated by estrogen, compared to a phase when ...
Cached Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:NIMH Studies Woman’s Hormonal Cycl 2
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
... Medtronic presents the Streamline family of ... have taken the gold standard in temporary ... that make them easy to use and ... Model 6491 Unipolar Pediatric Temporary Pacing Lead ...
Medicine Products: